Galmed Pharmaceuticals Ltd. buy Needham & Company LLC
Start price
25.02.26
/
50%
€6.40
Target price
25.02.27
€96.72
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 25.02.27. The prediction end date can be changed by Needham___Company_LL at any time.Performance without dividends (%)
| Name | 1w |
|---|---|
| Galmed Pharmaceuticals Ltd. | - |
| iShares Core DAX® | 1.232% |
| iShares Nasdaq 100 | 0.695% |
| iShares Nikkei 225® | 2.085% |
| iShares S&P 500 | 0.419% |
Comments by Needham___Company_LL for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical (GMED) had its price target raised by Needham & Company LLC from $112.00 to $114.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat